Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Orbital Therapeutics

Request full access

Aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease

San Francisco, United StatesFounded 2022Biotech & Life Sciences

About Orbital Therapeutics

Orbital Therapeutics is a pioneering startup in the field of RNA-based medicines, excluding small interfering RNA. The company is leveraging the power of RNA technology, delivery methods, data science, and automation to create a unique platform for the development of a broad range of medicines. Initially, the focus is on vaccines, immunomodulation, and protein replacement.

The company's mission is to improve global health by unlocking the full potential of RNA medicines to treat diseases in ways that were previously unattainable. The market it operates in is the pharmaceutical and biotechnology industry, specifically in the area of genetic medicine and RNA development and delivery.

Orbital Therapeutics' business model is based on the development and commercialization of RNA-based medicines. It generates revenue through the sale of these innovative medicines to healthcare providers and patients. The company's clients are primarily healthcare providers who administer the medicines to patients suffering from various diseases that can be treated with RNA-based therapies.

The company was founded by experts in genetic medicine and RNA development and delivery, including Dr. Giuseppe Ciaramella, who has over 20 years of drug discovery experience at leading pharmaceutical companies. Dr. Ciaramella's extensive experience in the field of antivirals, immunology, and biotherapeutics is instrumental in guiding the company's strategic direction and research efforts.

Source: Dealroom company data

Orbital Therapeutics in the San Francisco ecosystem

Live from Dealroom

The Orbital Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A11 investors entered at this stage

  • Invus
  • Moore Strategic Ventures
  • Heritage Medical Systems
  • iGlobe Partners
  • Casdin Capital
  • Alexandria Venture Investments
  • Exor
  • Abu Dhabi Growth Fund
  • Rellim Capital Management
  • Redmile Group
  • Agent Capital
Employees mapped 16 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 15 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Orbital Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.